{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T11:52:43Z","timestamp":1783511563928,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009037","name":"SATREPS","doi-asserted-by":"publisher","award":["JP17jm0110010"],"award-info":[{"award-number":["JP17jm0110010"]}],"id":[{"id":"10.13039\/501100009037","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP18fk0108042"],"award-info":[{"award-number":["JP18fk0108042"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004532","name":"Japan International Cooperation Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004532","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031489","name":"Shionogi Infectious Disease Research Promotion Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031489","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008660","name":"Kurozumi Medical Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008660","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ijid.2025.107895","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T18:23:34Z","timestamp":1743013414000},"page":"107895","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["One-year mortality of tuberculosis patients on isoniazid-based treatment and its association with rapid acetylator NAT2 genotypes"],"prefix":"10.1016","volume":"155","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1515-6238","authenticated-orcid":false,"given":"Ayu","family":"Kasamatsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1998-505X","authenticated-orcid":false,"given":"Reiko","family":"Miyahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3525-5092","authenticated-orcid":false,"given":"Daisuke","family":"Yoneoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9738-2441","authenticated-orcid":false,"given":"Licht","family":"Toyo-oka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boonchai","family":"Chiyasirinroje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Worarat","family":"Imsanguan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supharat","family":"Suvichapanich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Yanai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukanya","family":"Wattnapokayakit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supalert","family":"Nedsuwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6480-1257","authenticated-orcid":false,"given":"Manon","family":"Boonbangyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasit","family":"Palittapongarnpim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsushi","family":"Tokunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taisei","family":"Mushiroda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surakameth","family":"Mahasirimongkol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2025.107895_bib0001","series-title":"Global tuberculosis report 2024","year":"2024"},{"key":"10.1016\/j.ijid.2025.107895_bib0002","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1128\/AAC.49.5.1733-1738.2005","article-title":"Should we use N-acetyltransferase type 2 genotyping to personalize isoniazid doses?","volume":"49","author":"Kinzig-Schippers","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2025.107895_bib0003","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s00228-022-03362-7","article-title":"Influence of N-acetyltransferase 2 (NAT2) genotype\/single nucleotide polymorphisms on clearance of isoniazid in tuberculosis patients: a systematic review of population pharmacokinetic models","volume":"78","author":"Thomas","year":"2022","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ijid.2025.107895_bib0004","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2217\/pgs.11.122","article-title":"Accuracy of various human NAT2 SNP genotyping panels to infer rapid, intermediate and slow acetylator phenotypes","volume":"13","author":"Hein","year":"2012","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.ijid.2025.107895_bib0005","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1086\/424999","article-title":"The influence of human N-acetyltransferase genotype on the early bactericidal activity of isoniazid","volume":"39","author":"Donald","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2025.107895_bib0006","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/cid\/cis353","article-title":"Meta-analysis of clinical studies supports the pharmacokinetic variability hypothesis for acquired drug resistance and failure of antituberculosis therapy","volume":"55","author":"Pasipanodya","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2025.107895_bib0007","doi-asserted-by":"crossref","first-page":"e384","DOI":"10.1371\/journal.pmed.0030384","article-title":"Tuberculosis recurrence and mortality after successful treatment: impact of drug resistance","volume":"3","author":"Cox","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijid.2025.107895_bib0008","series-title":"Thailand operational plan, to end tuberculosis, phase 2 (2023-2027)","year":"2023"},{"key":"10.1016\/j.ijid.2025.107895_bib0009","doi-asserted-by":"crossref","first-page":"553","DOI":"10.4269\/ajtmh.19-0564","article-title":"Characteristics of poor tuberculosis treatment outcomes among patients with pulmonary tuberculosis in community hospitals of Thailand","volume":"102","author":"Charoensakulchai","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ijid.2025.107895_bib0010","doi-asserted-by":"crossref","DOI":"10.2147\/IJGM.S16486","article-title":"Time of highest tuberculosis death risk and associated factors: an observation of 12 years in Northern Thailand","author":"Aung","year":"2011","journal-title":"International Journal of General Medicine"},{"key":"10.1016\/j.ijid.2025.107895_bib0011","series-title":"Guideline for Programmatic Management of Drug-Resistant Tuberculosis","year":"2015"},{"key":"10.1016\/j.ijid.2025.107895_bib0012","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1473-3099(16)30407-8","article-title":"Treatment of isoniazid-resistant tuberculosis with first-line drugs: a systematic review and meta-analysis","volume":"17","author":"Gegia","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2025.107895_bib0013","series-title":"WHO Treatment Guidelines for Isoniazid-Resistant Tuberculosis: Supplement to the WHO Treatment Guidelines for Drug-Resistant Tuberculosis","year":"2018"},{"key":"10.1016\/j.ijid.2025.107895_bib0014","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1093\/jac\/dkac188","article-title":"Pharmacokinetics of standard versus high-dose isoniazid for treatment of multidrug-resistant tuberculosis","volume":"77","author":"Gausi","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2025.107895_bib0015","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1164\/rccm.202103-0534OC","article-title":"A semimechanistic model of the bactericidal activity of high-dose isoniazid against multidrug-resistant tuberculosis: results from a randomized clinical trial","volume":"204","author":"Gausi","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijid.2025.107895_bib0016","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/cid\/ciz039","article-title":"Improved outcomes with high-dose isoniazid in multidrug-resistant tuberculosis treatment in Haiti","volume":"69","author":"Walsh","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2025.107895_bib0017","doi-asserted-by":"crossref","first-page":"654","DOI":"10.2105\/AJPH.2010.199505","article-title":"The social determinants of tuberculosis: from evidence to action","volume":"101","author":"Hargreaves","year":"2011","journal-title":"Am J Public Health"},{"key":"10.1016\/j.ijid.2025.107895_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2020.101991","article-title":"Risk factors associated with large clusters of tuberculosis patients determined by whole-genome sequencing in a high-tuberculosis-burden country","volume":"125","author":"Miyahara","year":"2020","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.ijid.2025.107895_bib0019","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/jhg.2017.82","article-title":"Pathogen lineage-based genome-wide association study identified CD53 as susceptible locus in tuberculosis","volume":"62","author":"Omae","year":"2017","journal-title":"J Hum Genet"},{"key":"10.1016\/j.ijid.2025.107895_bib0020","first-page":"213","article-title":"Revised international definitions in tuberculosis control","volume":"5","year":"2001","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2025.107895_bib0021","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1128\/JCM.01946-14","article-title":"Evaluating the Auto-MODS assay, a novel tool for tuberculosis diagnosis for use in resource-limited settings","volume":"53","author":"Wang","year":"2015","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijid.2025.107895_bib0022","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation","volume":"526","author":"Auton","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ijid.2025.107895_bib0023","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1086\/519795","article-title":"PLINK: a tool set for whole-genome association and population-based linkage analyses","volume":"81","author":"Purcell","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ijid.2025.107895_bib0024","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00439-019-02014-8","article-title":"Is population structure in the genetic biobank era irrelevant, a challenge, or an opportunity?","volume":"139","author":"Lawson","year":"2020","journal-title":"Hum Genet"},{"key":"10.1016\/j.ijid.2025.107895_bib0025","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/aje\/kwg231","article-title":"Evaluating medication effects outside of clinical trials: new-user designs","volume":"158","author":"Ray","year":"2003","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ijid.2025.107895_bib0026","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s00228-012-1429-9","article-title":"NAT2 genotype guided regimen reduces isoniazid-induced liver injury and early treatment failure in the 6-month four-drug standard treatment of tuberculosis: a randomized controlled trial for pharmacogenetics-based therapy","volume":"69","author":"Azuma","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ijid.2025.107895_bib0027","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12890-016-0187-3","article-title":"Later emergence of acquired drug resistance and its effect on treatment outcome in patients treated with Standard Short-Course Chemotherapy for tuberculosis","volume":"16","author":"Gao","year":"2016","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.ijid.2025.107895_bib0028","first-page":"392","article-title":"Survival and relapse rate of tuberculosis patients who successfully completed treatment in Vietnam","volume":"11","author":"Vree","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2025.107895_bib0029","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2334-14-5","article-title":"Tuberculosis mortality: patient characteristics and causes","volume":"14","author":"Lin","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijid.2025.107895_bib0030","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s00228-007-0333-1","article-title":"Dose-escalation study of isoniazid in healthy volunteers with the rapid acetylator genotype of arylamine N-acetyltransferase 2","volume":"63","author":"Kubota","year":"2007","journal-title":"Eur J Clin Pharmacol"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971225001183?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971225001183?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T11:41:37Z","timestamp":1770205297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971225001183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":30,"alternative-id":["S1201971225001183"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2025.107895","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"One-year mortality of tuberculosis patients on isoniazid-based treatment and its association with rapid acetylator NAT2 genotypes","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2025.107895","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"107895"}}